Safety and tolerability study of claudiximab in patients with advanced gastroesophageal cancer

Trial Identifier: GM-IMAB-001
Sponsor: Ganymed Pharmaceuticals GmbH
Start Date: May 2009
Primary Completion Date: May 2010
Study Completion Date: May 2010
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Germany Essen, Germany, 45122
Germany Heidelberg, Germany, 69120
Germany Mainz, Germany, 55131
Germany München, Germany, 81674
Latvia Liepaja, Latvia, 3401
Latvia Riga, Latvia, 1002